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N-terminal acetylation (Nt-acetylation) by N-terminal
acetyltransferases (NATs) is one of the most common
protein modifications in eukaryotes. The NatC complex
represents one of three major NATs of which the
substrate profile remains largely unexplored. Here, we
defined the in vivo human NatC Nt-acetylome on a pro-
teome-wide scale by combining knockdown of its cata-
lytic subunit Naa30 with positional proteomics. We iden-
tified 46 human NatC substrates, expanding our current
knowledge on the substrate repertoire of NatC which now
includes proteins harboring Met-Leu, Met-Ile, Met-Phe,
Met-Trp, Met-Val, Met-Met, Met-His and Met-Lys N ter-
mini. Upon Naa30 depletion the expression levels of sev-
eral organellar proteins were found reduced, in particular
mitochondrial proteins, some of which were found to be
NatC substrates. Interestingly, knockdown of Naa30 in-
duced the loss of mitochondrial membrane potential and
fragmentation of mitochondria. In conclusion, NatC Nt-
acetylates a large variety of proteins and is essential for
mitochondrial integrity and function. Molecular & Cellu-
lar Proteomics 15: 10.1074/mcp.M116.061010, 3361–3372,
2016.
Protein N-terminal (Nt)1 acetylation is the transfer of an
acetyl moiety from acetyl coenzyme A (Ac-CoA) to the N-ter-
minal alpha-amino group of proteins. Nt-acetylation is one of
the most common protein modifications in eukaryotes (1–4)
and has a wide range of functional implications and impacts
protein-protein interactions (5), protein subcellular targeting
(6–10), protein folding (11), and ubiquitin-dependent degra-
dation of specific proteins thereby controlling protein stoichi-
ometry and quality (12, 13).
Nt-acetylation is catalyzed by evolutionarily conserved Nt-
acetyltransferases (NATs). NatA-NatF differ both with respect
to substrate specificity and subunit composition, where the
catalytic subunits are members of the GNAT acetyltransferase
superfamily. NATs can bind to ribosomes where they perform
Nt-acetylation in a co-translational manner (14). However,
post-translational Nt-acetylation of proteins has also been
reported (15–17). The NatC complex was originally identified
in yeast (18, 19) and we previously described the human NatC
complex, which is conserved from yeast both with respect to
subunit composition, ribosome binding, and in vitro oligopep-
tide substrate specificity (19, 20). NatC is composed of the
catalytic subunit Naa30 (Mak3) and the auxiliary subunits
Naa35 (Mak10) and Naa38 (Mak31), all of which cosediment
with ribosomes (20). Naa30 plays a role in stress resistance
in Caenorhabditis elegans (21). Previously it was found that
NatC Nt-acetylates Met-Leu-, Met-Ile-, Met-Phe- and Met-
Trp- N termini which are relatively rare as compared with
NatA and NatB type N termini (22–24). Of note is that NatC
does not acetylate all proteins matching these N-terminal
sequences and typically NatC substrates are less Nt-acety-
lated as compared with NatA and NatB substrates (1, 25).
As such, the full basis for substrate recognition by NatC is
not fully understood.
Several studies have indirectly linked NatC to organelle
traffic, as several Arf(-like) GTPases (i.e., hARFRP1, hArl8b)
have been put forward as NatC substrates. In the case of yArl3
and yGrh1, loss of Nt-acetylation in yNatC deletion strains re-
sulted in disruption of their localization to the Golgi apparatus
(6–8). Furthermore, hArl8b depends on Naa30-mediated acety-
lation for correct lysosomal localization (20, 26).
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Mitochondrial morphology is highly dynamic. Fission and
fusion reactions regulate the number, size, and movement of
mitochondria (27). Dysfunctional mitochondria are often as-
sociated with fragmentation, by which damaged mitochondria
are isolated to prevent their reentry into the mitochondrial
network. General defects in mitochondrial dynamics are
found in a number of neurodegenerative diseases including
Alzheimer’s, Huntington’s, and Parkinson’s disease (27).
Although fragmentation of mitochondria represents a fea-
ture of apoptosis (28), mitochondrial damage can also occur
and can be exacerbated by reactive oxygen species (ROS).
Under oxidative stress, damaged mitochondria are targeted
by mitophagy, a selective form of autophagy where mem-
branes encompass damaged mitochondria, giving rise to
membranous particles delivered to lysosomes for degradation
(27).
Currently, no studies have looked at human NatC mediated
Nt-acetylation at a proteome-wide scale. In this study we
aimed to define the in vivo substrate profile of hNatC by
positional proteomics (29), thereby aiding in elucidating the
functional role of NatC. Previously, only a handful of endog-
enous yeast NatC substrates have been identified. Our pro-
teome analysis revealed 46 human NatC substrates, thereby
greatly expanding our knowledge on the in vivo substrate
repertoire of NatC and including a wide variety of substrates
including the previously identified substrate hArl8b. Interest-
ingly and in line with the reduced levels of various mitochon-
drial (matrix) proteins observed, depletion of NatC’s catalytic
subunit Naa30 led to mitochondrial fragmentation and loss of
membrane potential. On the other hand, Naa30 depletion did
not affect the morphology and distribution patterns of the
endoplasmic reticulum (ER), endosome, and peroxisome, nor
the architecture of microtubules and the actin cytoskeleton,
suggesting that the observed mitochondrial fragmentation
is not the result of general disruption of organelles or mi-
crotubules. Overall, our results place Naa30 in mitochon-
drial function and Nt-acetylation of a wide range of iMet-
starting proteins.
EXPERIMENTAL PROCEDURES
Plasmids, Antibodies, and Vital Dyes—The following antibodies
were used for immunoblotting and/or immunofluorescence: anti-
UCRI (Santa Cruz Biotechnology, Santa Cruz, CA; sc-13561), anti-
EEA1 (Santa Cruz Biotechnology, sc-33585), anti-PDI (Thermo
Scientific, MA3–018), anti-PMP70 (Sigma-Aldrich, SAB4200181), an-
ti-COX IV-rabbit (Cell Signaling, 4850), anti-COX IV-mouse (Cell
Signaling, Danvers, MA; 11967), anti--actin (AbCam ab6276), anti-
-tubulin (Sigma-Aldrich, St. Louis, MO; T5293) and anti-Naa35 (Sig-
ma-Aldrich, HPA021547). Anti-Naa30 (Biogenes, Berlin, Germany)
was generated by immunizing rabbits with purified full-length recom-
binant human Naa30 protein produced in E. coli, followed by IgG
isolation from the resulting sera (20). Horseradish peroxidase-coupled
anti-mouse and anti-rabbit from Amersham Biosciences Biosciensce
were used as secondary antibodies for immunoblot detection.
Cell culture and transfection—Human A-431 cells (epidermoid car-
cinoma cell line) (ATCC, CRL-1555) were cultured in Glutamax-con-
taining DMEM medium supplemented with 10% dialyzed fetal bovine
serum (Invitrogen, Carlsbad, CA), 100 units/ml penicillin (Invitrogen)
and 100 g/ml streptomycin (Invitrogen). Cells were grown in media
containing either natural (12C6) or
13C6
15N4 L-arginine (Cambridge
Isotope Labs, Andover, MA) at a concentration of 80 M (i.e. 16.8 mg/l
or 20% of the suggested concentration present in DMEM at which
arginine to proline conversion was not detectable for A-431 cells).
Cells were cultured for at least six population doublings to ensure
complete incorporation of the labeled arginine. Cells were cultured at
37 °C in a humidified atmosphere of 5% CO2 in air. HeLa cells
(epithelial cervix adenocarcinoma; ATCC, CRL-1573) and CAL-62
cells (anaplastic carcinoma, 8305C, DSMZ, ACC 448) were cultured
and transfected as described previously (30). Cells were harvested
72 h post siRNA transfection. siRNA mediated knockdown was
performed using Dharmafect 1 transfection reagent (Dharmacon) or
HiPerFect (Qiagen) according to the vendors’ instructions. Gene-
specific siRNAs were purchased from Dharmacon and used at the
final concentration indicated and ranging between 20–100 nM to
silence Naa30. For all siRNA validation experiments two different
siRNAs targeting Naa30 were used to ensure that phenotypes were
specific for Naa30 depletion: sihNAA30–1 (Dharmacon, LAF, Colo-
rado; D-009961–01), and sihNAA30–2 (Dharmacon, D-009961–05).
Knockdown efficiency of Naa30 was inspected by immunoblotting.
Non-targeting siRNA (Dharmacon, D-001819–10) was used as a con-
trol. For siRNA transfections in A-431 cells, 10 M Z-VAD-fmk pan-
caspase inhibitor (R&D Systems Europe Ltd.) was added throughout
the experiment to avoid cell death, whereas 5 M Z-VAD-fmk was
used for siRNA transfections in HeLa cells.
N-terminal COFRADIC: Experimental Design and Statistical Ration-
ale—siRNA transfection was performed as described above and an
experimental workflow is given in Fig. 1. For transfections maintained
for more than 72 h, cells were retransfected using the same condi-
tions 48 h after the first transfection. Cells were harvested 96 h
post-siRNA transfection, lysed in 50 mM sodium phosphate buffer pH
7.5 and 50 mM NaCl supplemented with a complete protease inhibitor
mixture tablet (Roche Diagnostics GmbH, Mannheim, Germany) using
multiple cycles of freeze-thawing (3) and total lysates subjected to
N-terminal COFRADIC analysis as described previously (1). The or-
ganelle fraction was isolated as described below and subjected to a
modified sample preparation protocol optimized for fractions contain-
ing less soluble proteins. In brief, all modifications were performed
using similar conditions as in (31), however in between all modification
steps, the insoluble organelle fraction was pelleted, washed, and
resuspended in the respective buffer supplemented with the modify-
ing agent(s), and sonicated with a probe sonicator for 5 min using 3 s
pulses in an ice/water bath. Following these protein modification
steps, the insoluble pellet was dissolved in 10 mM ammonium bicar-
bonate buffer (pH 8.0) by sonication and digested overnight with
sequencing-grade modified trypsin (1/100 (w/w trypsin/substrate)) at
37 °C. Subsequent steps of the N-terminal COFRADIC procedures
were performed as in (31).
The analysis of the fractionated samples served to increase the
total proteome coverage and to uncover possible differences in the
degree of Nt-acetylation of proteins found in both fractions, if any. In
both setups analyzed, making use of an N-hydroxysuccinimide ester
of (stable isotopic encoded) acetate at the protein level (i.e. NHS
esters of 13C2D3 acetate), in vitro
13C2D3-acetylation was used in
combination with differential L-Arg SILAC (stable isotope-labeling by
amino acids in cell culture) labeling, which allows for the calculation of
the extent of Nt-acetylation as well as the relative quantification of
N-terminal peptides (2, 32). Further, given the known and expected
substrate specificities of the different NATs, we enriched for NatB,
NatC, NatE, and NatF substrates, i.e. Met-starting N-terminal pep-
tides, during the COFRADIC sorting step (32). For this, a methionine
oxidation step was introduced between the primary and secondary
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RP-HPLC separations, thereby shifting all methionine-containing N-
terminal peptides to earlier elution times, allowing an enrichment of
these (32).
All quantifications (12C6 L-arginine versus
13C6
15N4 L-arginine) were
carried out using the Mascot Distiller Quantitation Tool (version 2.2.1).
The quantification method details were as follows: constrain search:
yes; protein ratio type: average; report detail: yes; minimum peptides:
1; protocol: precursor; allow mass time match: yes; allow elution shift:
no; all charge states: yes; fixed modifications: mass values. Mascot
Distiller tries to fit an ideal isotopic distribution on the experimental
data based on the peptide average amino acid composition. This
fitting is followed by extraction of the XIC signal of all light (12C6
L-arg) and heavy (13C615N4 L-arg) peptide components from the raw
data. Subsequently, peptide ratios are calculated by comparing the
XIC peak areas of all matched light versus heavy peptides (integration
method “trapezium,” integration source “survey”). To calculate this
ratio value, a least squares fit to the component intensities from the
different scans in the XIC peak is created. MS scans used for this ratio
calculation are situated in the elution peak of the precursor deter-
mined by the Distiller software (XIC threshold 0.3, XIC smooth 1, Max
XIC width 250). To validate the calculated ratio, the standard error on
the least square fit has to be below 0.16 and correlation coefficient of
the isotopic envelope should be above 0.97. The calculated ratios
originally reported as FALSE were all verified by visual inspection of
the highest scoring MS spectra. All protein N termini were corrected
according to the deviation of a 1:1 ratio of protein-N termini in both
analyses.
A distribution of all individual peptide ratios was determined fol-
lowed robust statistics. Peptides displaying a ratio that was signifi-
cantly up- or downregulated (95% confidence interval) were consid-
ered affected by the hNAA30 knockdown. Quantification of the
degree of Nt-acetylation was performed as described in (33). When
comparing the degrees of Nt-acetylation from two independent con-
trol experiments (with the degrees of Nt-acetylation of more than
1000 unique N termini calculated) and taking into account a [x – 10%,
x 10%] interval around the calculated x-value (the x-value being the
degree (%) of Nt-acetylation for the calculated data point in one data
set), the p value was calculated to be p  0.01, indicating that upon
setting these limits, less than 1% of all measured Nt-Ac values
differed more than 10%. Therefore, a significant variation in the de-
gree of Nt-acetylation was set to 10% or more.
LC-MS/MS Analysis and Data Storage—The obtained peptide mix-
tures were introduced into an LC-MS/MS system, the Ultimate 3000
(Dionex, Amsterdam, The Netherlands) in-line connected to an LTQ
Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Bremen,
Germany) and LC-MS/MS analysis was performed as described pre-
viously (1, 2). The generated MS/MS peak lists were searched with
Mascot using the Mascot Daemon interface (version 2.2.0, Matrix
Science). Searches were performed in the Swiss-Prot database with
taxonomy set to human (UniProtKB/Swiss-Prot database version
2014_02, containing 20,256 human entries). 13C2D3-acetylation of
lysine side-chains, carbamidomethylation of cysteine and methionine
oxidation to methionine-sulfoxide were set as fixed modifications
for the N-terminal COFRADIC analyses. Variable modifications were
13C2D3-acetylation and acetylation of protein N termini. Pyrogluta-
mate formation of N-terminal glutamine was additionally set as a
variable modification. Mass tolerance on precursor ions was set to 10
ppm (with Mascot’s C13 option set to 1) and on fragment ions to 0.5
Da. Endoproteinase semi-Arg-C/P (Arg-C specificity with arginine-
proline cleavage allowed) was set as enzyme allowing no missed
cleavages. The peptide charge was set to 1, 2, 3, and instru-
ment setting was put to ESI-TRAP. Only peptides that were ranked
one, have a minimum amino acid length of seven and scored above
the threshold score, set at 99% confidence, were withheld. The
estimated false discovery rate by searching decoy databases (a shuf-
fled version of the yeast Swiss-Prot database made by the DBToolkit
algorithm (34)) was below 1.5% on the spectrum level and below 2%
at the peptide level. All data management was done in ms_lims
(35). The mass spectrometry proteomics data have been deposited
to the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE partner repository (36) with the
data set identifier PXD000930 and DOI 10.6019/PXD000930.
Cell Lysis and Organelle Sedimentation—The fractionated samples
used for COFRADIC analysis were harvested, resuspended in cell
homogenization buffer (0.25 M sucrose, 1 mM EDTA, 20 mM HEPES-
NaOH, pH 7.4), and homogenized using six strokes through a cell
crusher with 4 mm gap. Approximately 5  107 cells (A-431) were
used per sample. Nuclei were removed through sedimentation at
3000  g for 5 min. To separate organelles from cytosol, the homo-
genate was further centrifuged at 17,000 g for 20 min. The resulting
pellet contains organelles and plasma membrane, whereas the su-
pernatant contains the cytosol devoid of membranous and organelle
compartments. The supernatant and the pellet were further prepared
for analysis by N-terminal COFRADIC, as described above. In parallel,
cells were analyzed for the efficiency of knockdown, harvested by
scraping and pelleted by centrifugation at 2000  g for 5 min. Total
cell lysates were prepared by resuspending cell pellets in lysis buffer
(50 mM Tris/HCl pH 8, 50 mM NaCl, 0.5% Nonidet P40, 5 mM EDTA,
1 mM Na3VO4, and 1 mM Pefabloc (Roche)) and incubation on ice for
5 min. Cell debris was removed by centrifugation at 15,700  g for 1
min, and the supernatant transferred.
Immunofluorescence and Statistical Data Analysis—HeLa or
CAL-62 cells grown on cover slips were washed in PBS or cytoskel-
eton buffer (134 mM NaCl, 5 mM KCl, 1.1 mM Na2HPO2.2H2O, 0.4 mM
KH2PO4, 5.5 mM glucose, 4 mM NaHCO3, 10 mM MES, 2 mM EGTA, 2
mM MgCl2), fixed in 3% paraformaldehyde, permeabilized in 0.2%
Triton X-100, and blocked in 10% BSA. Proteins of interest were
labeled with primary antibodies as indicated (1:250). Secondary an-
tibodies were Alexa Fluor 488-, 594- or 555-conjugated IgGs (Invit-
rogen) (1:200). Blue 4,6-diamidino-2-phenylindole (DAPI) staining
was used to stain the nuclei. MitoTracker® Red CMXRos was added
to live cells according to the manufacturer’s instructions (Life tech-
nologies, M-7512) at a final concentration of 50 nM. Rhodamine
phalloidin was added to fixed cells to visualize actin according to the
manufacturer’s instructions (Life technologies, R415). In cases when
double labeling with mouse primary antibodies was performed, sam-
ples were incubated with goat anti-mouse IgG (H  L) Fab fragments
(1:100) after an incubation of the first mouse primary antibody. This
incubation was followed by incubation of with donkey anti-goat Alexa
secondary antibody and then in blocking buffer (PBS, 10% BSA, 5%
goat serum). Next, the second primary mouse antibody was added to
the samples, followed by goat anti-mouse Alexa secondary antibody.
Between all incubations the samples were washed in 0.1% Triton
X-100. Images were acquired using a Leica DMI 6000b microscope or
a Leica TCS SP5 confocal microscopy. Where indicated, microscopic
recordings were processed by de-convolution with 10 iterations using
3D Blind settings from 12–18 z-planes (Leica software). Z-stacks and
Z-stack projections were handled using the Fiji Image Processing
Software. Brightness and contrast were adjusted using the Fiji Image
Processing Software. The data for quantification after hNAA30 knock-
down are shown as the mean of at least 100 cells counted in three
independent samples.
Data for quantification of phenotypes after Naa30 knockdown were
analyzed using SPSS or Prism statistical software package. Student’s
t test was used to compare the mean percentage of defined pheno-
types in siNAA30 versus siCTR samples. Significance level was set to
p  0.05 for all analyses.
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RESULTS
COFRADIC Analysis of hNAA30 Knockdown Cells Reveals
Novel Human NatC Substrates—We characterized the in vivo
substrate specificity of the human NatC complex by compar-
ing the Nt-acetylomes of A-431 cells treated with sihNAA30
versus siControl treated cells (siCTR) (Fig. 1A). Here a knock-
down efficiency of more than 95% could be observed (Fig.
1B). Interestingly, Naa35 and Naa38 were also significantly
depleted upon sihNAA30-mediated knockdown (Fig. 1 and
supplemental Table S1). Next to total cell lysates, samples
enriched for cytoplasmic and organellar fractions were ana-
lyzed (Fig. 1A). A GO-enrichment analysis pointed to a signif-
icant enrichment of organelle proteins in the organelle versus
cytosolic enriched fractions and thus efficient fractionation
(supplemental Fig. S1).
Following LC-MS/MS analysis, we identified 1874 unique
N termini with a minimum amino acid length of seven orig-
inating from 1754 human proteins that were in compliance
with the rules of Nt-acetylation (37) and initiator methionine
(iMet) processing, thereby being proxies of translation initi-
ation (supplemental Table S1). Of these, 1855 started at
position 1 or 2, whereas 19 started beyond position 2, the
latter indicative of alternative translation initiation events
(16, 38).
In total, 46 N termini displayed a 10% reduction in their
degree of Nt-acetylation upon hNAA30 knockdown, a cut-off
value where the false discovery rate when studying differ-
ences in the degree of Nt-acetylation was found to be less
than 1% (see Experimental Procedures). These N termini all
started with an iMet as reflected by their Swiss-Prot database
annotated start position of 1. Based on the sihNAA30 de-
pendent reduction in their degree of Nt-acetylation, the iden-
tification of the previously characterized substrate hArl8b (20,
26) and the substrate specificity profile observed, we consider
these N termini as direct Naa30 substrates and they thus
constitute part of the in vivo substrate repertoire of the human
NatC complex (Table I and supplemental Table S1B) (14).
Representative MS spectra of sihNAA30 affected substrate N
termini of the cell differentiation protein RCD1 homolog and
the hydroxysteroid dehydrogenase-like protein 2 (HSDL2)
identified in the total cell lysate setup are shown in Fig. 2A
and 2B.
Many of the here identified substrates are previously un-
identified NatC substrates not belonging to the class of pre-
dicted NatC-type N termini (holding Met-Leu, Met-Ile, Met-
Phe, and Met-Trp N termini) (22–24). Indeed, our data reveal
that human NatC in vivo additionally acetylates N termini
starting with Met-Lys, Met-Val, Met-His, and Met-Met N ter-
mini (Table I and supplemental Table S1B). Of note, as siRNA-
mediated knockdown does not lead to a full depletion of the
target protein, mostly suboptimal (i.e. not fully acetylated)
NatC-type N termini displayed reduced Nt-acetylation (Fig.
2C), an observation previously also seen for hNatA and hNatB
substrates (1, 25). Further, no Met-Trp and Met-Ile N termini
were identified among the Naa30 substrates.
hNAA30 Substrates Are Not Enriched for Organellar Local-
ization—As described above, several studies have linked
NatC to organelle traffic. In yeast, it was previously shown that
proteins harboring a signal or transit peptide are highly pro-
FIG. 1. Experimental workflow and confirmation of the effi-
ciency of hNAA30-knockdown. A, Workflow of sample preparations
for N-terminal COFRADIC. B, Immunoblots of A-431 cell lysates
treated with non-targeting siRNA (siCTR) or sihNAA30. Cells were
harvested 96 h post siRNA transfection. Blots were probed with
anti-Naa30 and anti-Naa35 to assess levels of endogenous Naa30
and Naa35. The asterisk indicates nonspecific bands that serve as
loading control.
TABLE I
NatC type N-termini: their Nt-acetylation status and Naa30 depend-
ency of Nt-acetylation. All types of N-termini identified in this study
matching previously reported NatC substrate specificities (ML-, MY-,
MF-, MI-) (22–24) as well as the previously uncharacterized hNatC
substrate specificities identified in this study (MM-, MH-, MV-, and
MK-) are listed. In all cases, the numbers of uniquely identified N-ter-
mini, the number of N-termini for which the degree of Nt-Acetylation
could be univocally calculated/determined and their corresponding
number and proportion of complete and partial acetylation is indi-
cated. Whenever a reduced degree of acetylation could be observed
upon sihNAA30 knockdown the corresponding number and propor-
tion of affected N-termini are indicated
NatC
substrate type Identified
Nt-Ac
determined
Full  partial
Nt-Ac (%)
sihNAA30
affected
Met-Met 17 16 16 (100%) 1 (6%)
Met-His 3 3 3 (100%) 1 (33%)
Met-Leu 50 48 43 (90%) 18 (42%)
Met-Tyr 9 9 8 (89%) 0 (0%)
Met-Val 41 40 34 (85%) 8 (24%)
Met-Phe 24 23 19 (83%) 5 (26%)
Met-Ile 12 12 8 (67%) 0 (0%)
Met-Lys 52 50 30 (60%) 13 (43%)
Total 208 201 161 (80%) 46 (29%)
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tected against removal of their initiator methionine as they
have a higher frequency of bulky and basic amino acids (Leu,
Ile, Trp, Lys and Arg) at position 2 (10). This was also evident
when searching the human Swiss-Prot database for proteins
holding a transit or signal sequence at their N terminus (sup-
plemental Fig. S2). These proteins typically have Arg, Leu, Lys
and Trp as their second amino acid, which partly overlaps
with our revised NatC substrate specificity profile (Table I).
Further, these signal peptides typically encompass around 16
to 30 amino acids, including at least one positively charged
residue, followed by 6 to 12 hydrophobic residues. Despite
this indication for organelle localization of several human
NatC substrates, we did not find a significant enrichment for
organellar proteins by gene ontology analysis among the
identified NatC substrates (data not shown). More specifically,
organelle-localized substrates constitute about 20% of the
FIG. 2. The effect of Naa30 knockdown on the Nt-acetylation states of individual proteins and the Nt-acetylome. A, Representative MS
spectrum of the N terminus originating from the cell differentiation protein RCD1 homolog (1MHSLATAAPVPTTLAQVDR19). The peptide was
fully acetylated in the control setup while being only partially acetylated (83%) in the sihNAA30 knockdown sample. The total concentration
of the N terminus remained unaffected in the two samples analyzed (ratio of 1). B, Representative MS spectrum of the N terminus of the
hydroxysteroid dehydrogenase-like protein 2 (1MLPNTGR7). The peptide was partially acetylated in both control (32%) and knockdown (3%)
samples. The total concentration of the N terminus is significantly lowered upon sihNAA30 knockdown (p  0.01; ratio of 0.5). C, The
scatterplot displays the correlation of the determined degrees of Nt-acetylation when comparing the siCTR (X-axis) and the sihNAA30(Y-axis)
N-terminome data sets (N termini with start position 1 or 2) of the total lysate samples (n  1065). The circles falling outside the 10%
boundaries (dashed lines) represent N termini displaying a significant reduction in the degree of Nt-acetylation upon sihNAA30 knockdown (2).
The circles are color coded according to their indicated NAT substrate specificity profiles (see also NAT type column in supplemental Table
S1). sihNAA30 knockdown causes a decrease in the levels of Nt-Ac as compared with the siCTR setup only for specific N termini in the NAT
type categories of “NatC” or “Other” N termini.
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human NatC substrates identified, whereas the majority is
cytosolic, nuclear or cytoskeleton associated (supplemental
Fig. S1). Of note however is that the rapid removal of protein
signal sequences accompanying organellar protein transport
may largely account for this (see also below for the identifi-
cation of mature/processed mitochondrial protein N termini).
Furthermore, whenever protein N termini were identified in
multiple fractions (i.e. total lysate, organelle and/or cytosol
enriched fraction from siCTR and/or sihNAA30 setups) no
notable differences in their degree of Nt-acetylation could be
observed. This indicates that Nt-acetylation is not critically
involved in steering the localization of proteins with multiple
subcellular localization patterns identified in our study (sup-
plemental Table S1).
hNAA30 Knockdown Negatively Impacts Mitochondrial Pro-
tein Levels—With the proteomics data at hand, we also mon-
itored possible differences in protein levels based on compar-
ing the MS-signal intensities of N-terminal peptides identified
in the siCTR and sihNAA30 samples that were identified in the
total lysate sample (supplemental Table S1B). In total, 43
unique protein N termini displayed significantly altered steady
state levels (p  0.05). Note that only 9 of 43 proteins dis-
played an elevated protein level upon Naa30 depletion,
whereas the remaining 34 displayed decreased protein levels.
Among these 43 regulated proteins, eight proteins were here
identified as NatC substrates, and all eight displayed signifi-
cantly reduced protein levels upon Naa30 depletion in the
total lysate setup. Interestingly, proteins with decreased levels
upon Naa30 depletion were enriched for mitochondria-local-
ized proteins. Indeed, when searching for enriched GO terms
indicative of protein subcellular localization among regulated
proteins, GO terms such as mitochondrial part (and related
terms) were found significantly enriched (p value  4.44 
10	6) using GOrilla.
To more globally assess changes in the mitochondrial pro-
teome, we additionally considered the expression ratios of
proteolytic N termini indicative of mitochondrial protein proc-
essing events (i.e. in vivo Nt-free N termini starting beyond
position 2 originating from mitochondrial proteins, and thus
serving as proxies of N-terminal signal peptide removal upon
mitochondrial protein import among others) (supplemental
Table S1). Interestingly, clearly distinct profiles could be ob-
served when comparing the ratio density plots (log2) of data-
base annotated N termini versus N termini indicative of mito-
chondrial processing events (Fig. 3A), the latter showing two
distinct populations. Upon closer inspection, we observed
that the expression ratios of mitochondrial matrix proteins
were specifically affected as processed mitochondrial matrix
proteins displayed significantly reduced expression levels as
determined by a Chi-squared test of Independency (p value
0.00001). Additionally, NatC type substrates appeared en-
riched in the category of mitochondrial matrix proteins
whereas NatB type substrates were underrepresented (Fig.
3B). Overall, these findings point to a general clearance of
mitochondria, likely by mitophagy (39), upon hNAA30 knock-
down, bringing along the selectively reduced levels of mito-
chondrial matrix proteins, a class enriched in NatC substrates.
Given these data we hypothesized that mitochondria were
impaired in hNAA30 knockdown cells.
hNAA30 Knockdown Induces Mitochondrial Fragmenta-
tion—To investigate the effect of NatC depletion on mitochon-
dria in more detail, we compared the mitochondrial morphol-
ogy of sihNAA30 and siCTR treated HeLa cells. Mitochondria
were visualized by immunofluorescence microscopy and
staining cells for the cytochrome c oxidase subunit IV (COX
IV), which is localized to the inner mitochondrial membrane. In
untreated and siCTR treated HeLa cells, mitochondria are
typically organized in a thread-like continuous network that
spans the entire cell and appear to be present in a higher
density close the nucleus and more dispersed toward the cell
perimeter (Fig. 4). In CAL-62 cells mitochondria are typically
FIG. 3. hNAA30 knockdown impacts mitochondrial matrix protein
levels, a category of proteins enriched for NatC type substrates. A,
Density plots of log2 transformed sihNAA30/siCTR ratios of all unique N
termini (1149), (processed) mitochondrial N termini (116) and (pro-
cessed) mitochondrial matrix protein N termini (54) identified in the total
lysate setup. B, Bar chart of the NAT-type substrate specificity distri-
bution of all initiator methionine (iMet) starting Swiss-Prot protein entries
(25744), mitochondrial proteins excluding mitochondrial matrix proteins
(761) and mitochondrial matrix proteins (304).
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FIG. 4. sihNAA30-treated cells display fragmented mitochondria. HeLa (A, B) and CAL-62 (C, D, E) cells depleted for Naa30 were
immunostained for the mitochondrial marker COX IV-mouse (A) or COX IV-rabbit (C, E). Micrographs were taken with a confocal and
Z-stacks were Z-projected to visualize COX IV. DAPI (blue) was used to visualize the nuclei (A, C) in overlay with COX-IV (red). The confocal
micrograph in (E) was taken with a 6.5 zoom and deconvoluted.White bars correspond to 10 m. The percentages of cells with perinuclear
and fragmented mitochondria were calculated for each sample (B, D). Data are mean and standard deviations from three independent
experiments (n  100–150). The difference between siCTR and sihNAA30 treated cells was statistically significant (p  0.05, student t
test). (F) Immunoblots of cell lysates from HeLa cells treated with nontargeting siRNA (siCTR) or sihNAA30. Cells were harvested 72 h post
siRNA transfection. Blots were probed with anti-Naa30 to assess levels of endogenous Naa30. -tubulin was used as loading control.
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clustered at one nuclear side and not spanning the entire cell.
Occasionally they have a similar mitochondrial network ar-
rangement as observed in HeLa cells (Fig. 4). In cells where
apoptosis has been induced by staurosporin treatment, the
mitochondrial network appears to be reduced in complexity
with swollen parts, and perinuclear localization (supplemental
Fig. S3). Interestingly, in sihNAA30 treated HeLa cells we
observed a large percentage of cells with altered mitochon-
drial morphology. These cells have lost their longer thread-like
mitochondria, which are instead present as fragmented,
smaller units that are mostly circular in shape. In addition, they
do not span the entire cell, but are usually concentrated
around the nucleus (Fig. 4A, 4B). A cell was counted as
fragmented when it displayed an alteration in morphology as
compared with the morphology of the vast majority of the
cells in untreated and siCTR treated cells. This change in
morphology was defined as a high degree of fragmentation
present as smaller discontinuous units of mitochondria, usu-
ally concentrated around the nucleus, and loss of a continu-
ous thread-like mitochondrial network. Because anaplastic
thyroid carcinoma CAL-62 cells contain a non-functional form
of p53 (30), we also depleted Naa30 in these cells, and inves-
tigated the morphology of mitochondria by COX IV staining.
Naa30-depletion induced redistribution of mitochondria to-
ward the nucleus and an increased fragmentation and clear-
ance after Naa30 depletion (Fig. 4C–4E). Overall, we conclude
that depletion of Naa30 leads to mitochondrial fragmentation,
perinuclear redistribution and clearance, independent of p53-
induced apoptosis. In both cell types, the difference in mito-
chondrial fragmentation between siCTR and sihNAA30
treated cells was found to be statistically significant (p 0.05,
student t test) (Fig. 4B, 4D). The mitochondrial fragmentation
and clearance observed in HeLa and CAL-62 cells upon
hNAA30 knockdown supports the proteomics data derived
from A-431 cells and suggest that the mitochondrial effects
observed are not cell line specific. Western blot analysis was
performed for each experiment to confirm hNAA30 knock-
down efficiency on Naa30 protein levels (Fig. 4F).
hNAA30 Knockdown Does Not Cause Global Disturbances
in Organelle Homeostasis—Because mitochondrial morphol-
ogy is strongly dependent on ER-induced fission (27) and
microtubular (40) and actin cytoskeletal changes (41) we as-
sessed if the observed mitochondrial effect was caused by a
more generalized abrogated cellular architecture and thus
investigated the implication of Naa30 perturbation on organ-
elle organization in general. More specifically, we investigated
the morphology and distribution patterns of several other
organelles as well as cytoskeletal integrity. Overall, we could
not observe any global changes in morphology and distribu-
tion of the ER, microtubules, actin cytoskeleton, early endo-
somes and peroxisomes (supplemental Fig. S6), indicating
that Naa30 depletion does not globally affect organellar struc-
tures or cytoskeletal rearrangements.
hNAA30 Knockdown Induces Functional Impairment of the
Mitochondria—To investigate if mitochondria were still func-
tional upon hNAA30 knockdown, we stained siCTR and sih-
NAA30 treated HeLa cells with the vital mitochondrial dye
MitoTracker Red CMXRos. Accumulation of this dye depends
on the mitochondrial membrane potential generated across
the inner mitochondrial membrane during ATP production
(42). Loss of membrane potential and thus loss of MitoTracker
Red CMXRos staining can be used as a parameter to assess
mitochondrial impairment (43). In sihNAA30 treated cells,
MitoTracker Red CMXRos typically did not stain fragmented
mitochondria, but rather shows a more diffuse cytoplasmic
staining (Fig. 5), which indicates that mitochondria in Naa30
depleted cells are functionally impaired as compared with
siCTR treated cells. In fact, note that all counted sihNAA30
FIG. 5. MitoTracker Red CMXRos staining reveals non-functional mitochondria in sihNAA30 treated cells. Confocal micrographs of
siRNA treated HeLa cells stained with MitoTracker Red CMXRos. All cells displaying a phenotype of fragmented mitochondria are not or only
partially stained by MitoTracker Red CMXRos. At least 100 cells in three independent parallels were observed. DAPI was used to visualize
nuclei. White bar indicates 10 m.
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treated cells with fragmented mitochondria demonstrated re-
duced or loss of CMXRos staining.
Loss of Nt-acetylation was previously shown to affect the
subcellular localization of a few substrates (6–9). We therefore
tested whether sihNAA30 treatment affected subcellular lo-
calization of the here-identified mitochondrial Naa30 sub-
strates metaxin-1 (MTX-1), cytochrome b-c1 complex subunit
Rieske (UCRI), mitochondrial 28S ribosomal protein S36
(MRPS36), and the hydroxysteroid dehydrogenase-like pro-
tein 2 (HSDL2). MTX-1, UCRI and MRPS36 and HSDL2 all
displayed a strong co-distribution with the mitochondrial
marker COX IV in both siCTR and sihNAA30 treated cells
(supplemental Fig. S4). Even though mitochondrial morphol-
ogy was altered by sihNAA30 treatment, the codistribution
patterns of MTX-1, UCRI, MRPS36, and HSDL2 with COX IV
were not altered. In line with previous data on HSDL2 local-
ization data, the observed dual cytoplasmic and peroxisomal
staining pattern of HSDL2 appeared not to be affected by
sihNAA30 treatment (supplemental Fig. S5) (44, 45), and these
observations were additionally confirmed in CAL-62 cells
(data not shown).
DISCUSSION
We here investigated the substrate repertoire of human
NatC, which was now found to include proteins harboring
Met-Leu, Met-Ile, Met-Phe, Met-Trp, Met-Val, Met-Met, Met-
His, and Met-Lys N termini. This reveals a substrate specificity
overlap of human NatC with NatE and NatF, which have been
demonstrated to acetylate some of these N-terminal se-
quences (2, 46, 47) and might indicate a redundancy between
these NATs. However, differences in the subcellular localiza-
tion and functional partners might direct these NATs to dif-
ferent substrate pools in vivo. Indeed, a recent study revealed
that NatF (Naa60) localizes to organellar membranes and
specifically Nt-acetylates transmembrane proteins harboring
a cytosolic N terminus (48). In contrast to the identified NatF
substrates, in the current data set there was no enrichment for
transmembrane proteins among identified NatC substrates
(48). Furthermore, NatE (Naa50) acts in physical association
with NatA, and was suggested to have a role in the Nt-
acetylation of non-iMet cleaved N termini of the NatA-class
(e.g. Met-Thr-, Met-Ala-, Met-Ser- etc.) (49). Interestingly,
several of the NatC substrates detected do not match previ-
ous types of NatC-type substrate N termini (i.e. Met-Leu,
Met-Trp, Met-Ile, Met-Phe) (Table I) (20, 50). In this study we
find that human NatC in vivo acetylates Met-Lys, Met-His,
Met-Met, and Met-Val in addition to Met-Leu and Met-Phe,
the latter two specificities matching previously annotated
NatC type substrate N termini (Table I). Unexpectedly, we
could not detect any changes in the levels of Nt-acetylation
annotated Met-Ile (Table I) N termini. Besides, no Met-Trp N
termini were identified in our study, the latter possibly be-
cause of the scarcity of detectable (mature) N termini (1.3% of
the human proteome) (2). When considering those type of
protein N termini displaying the observed NatC substrate
specificity profile (i.e. putative Naa30 substrate N termini
starting with Met-Phe, Met-His, Met-Lys, Met-Leu, Met-Met,
Met-Val), 35% of the putative candidate NatC substrates were
identified in this study as genuine NatC substrates (i.e. for
NatC type N termini of which the degree of Nt-acetylation
could univocally be assigned in both setups) (i.e. 29 of 82
proteins in total lysates). Interestingly, none of the N termini
affected by hNAA30 knockdown harbor an acidic amino acid
at position 3 or 4 (Met-x-(x)-Glu/Asp, where x  Leu/Lys/Val/
Met/Phe). This could indicate that the presence of an acidic
residue at these positions steers NatC-mediated Nt-acetyla-
tion. In addition, these N termini are typically Nt-acetylated to
a higher degree as compared with their nonacidic residue
containing counterparts. Previous N-terminomics studies
demonstrated that higher eukaryotes have an increased level
of Nt-acetylation as compared with lower eukaryotes, which is
partially attributed to the lack or very rare occurrence of
Nt-acetylation of Met-Lys in yeast (2). Thus, Nt-acetylation of
Met-Lys and potentially other types of N termini by human
NatC, together with NatF and perhaps NatE, likely contributes
to the increased levels of Nt-acetylation in higher eukaryotes.
Further, as knockdown of NAA30 resulted not only in the
depletion of Naa30 but also Naa35 and Naa38, thereby re-
flecting the effects of depleting the entire NatC complex, this
indicates a vital role for Naa30 in maintaining Naa35 and
Naa38 protein levels.
Several studies have pointed toward a possible role of NatC
in the subcellular localization of proteins and organelle orga-
nization. Although gene ontology analysis of human NatC
substrates did not reveal any pronounced enrichment for
organelle localization, we observed a significant enrichment of
mitochondrial proteins among the proteins with significantly
altered protein levels (supplemental Table S1C). This particu-
lar data set is only based on statistically significant differences
of MS-intensities from N termini (typically a single peptide per
protein), but it seems to be accurate enough to provide clues
for further investigation. Indeed, the majority of proteins with
reduced levels were significantly overrepresented by mito-
chondrial proteins hinting to the fact that hNAA30 knockdown
affects mitochondria. Moreover, (mature) mitochondrial matrix
proteins displayed significantly reduced expression levels as
compared with mitochondrial nonmatrix proteins. Although
degradation of outer membrane proteins of depolarized mito-
chondria is mediated by proteasome-dependent degradation,
degradation of matrix proteins largely depends on mitophagy
(39, 51). Besides, previous studies demonstrated that mito-
chondrial complex III—of which all components were here
found to be downregulated—acts as a specific positive reg-
ulator of autophagy (52) and that coenzyme Q deficiency
triggers mitophagy (53). We also noticed the up-regulation of
the autophagy protein Ambra 1 (activating molecule in BECN1
regulated autophagy), a factor critically involved in mitochon-
drial clearance (54, 55) and its up-regulation, together with
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the observation of mitochondrial depolarization in hNAA30
knockdown cells leads us to speculate that the loss of Nt-
acetylation of one or more NatC substrates causes mitochon-
drial damage and mitophagy. Mitophagy degrades damaged
mitochondria by autophagosomal delivery to lysosomes (56),
a process often accompanied by mitochondrial fission facili-
tating degradation of mitochondria (57). In line, immunofluores-
cence studies revealed a clear effect of Naa30 depletion on
mitochondria as they were more fragmented in hNAA30 knock-
down cells. With respect to differences in protein levels, only the
data set of the total lysate sample was considered because the
large differences in mitochondrial morphology in sihNAA30
treated cells might have perturbed subcellular fractionation, and
thus extraction of proteins in the fractionated samples.
Naa30 depletion was previously reported to be involved in
p53-dependent apoptosis (20). Mitochondrial fragmentation
and clearance is associated with cell death (58) and it has
been reported that treatment with pan-caspase inhibitors dur-
ing apoptosis will selectively remove mitochondria from cells
(59). However, in this study we verified the mitochondrial
phenotype in CAL-62 cells which express mutated, nonfunc-
tional p53 and without the addition of pan-caspase inhibitor
(Fig. 4). Further, in contrast to apoptotic cells, mitochondrial
fragmentation appears limited in sihNAA30 treated cells and
no cells with fragmented nuclei were observed. Thus, the
observed effects are not likely to be dependent on apoptosis.
By means of immunofluorescence studies, we could not
observe any obvious changes in subcellular localization for
the mitochondrial substrates investigated, indicating that Nt-
acetylation by NatC is not a general determinant of subcellular
localization, observations in agreement with a previous study
on yeast NatC substrates (60). Eight NatC substrates were
found to display reduced protein levels upon Naa30 depletion
(supplemental Table S1C), which could indicate that they are
targeted for degradation by the N-end rule pathway (12, 13,
61). Three of the substrates with reduced protein level are
mitochondrial proteins that appear to be cleared from the cell
(UCRI, MRPS36 and HSDL2, supplemental Fig. S4), whereas
the nonmitochondrial fraction of UCRI and HSDL2 appear to
be unaffected.
Here, we show that the human NatC complex Nt-acetylates
a broad range of cellular proteins, and that depletion of the
catalytic subunit Naa30 affects mitochondrial morphology
and function. However, the molecular mechanisms involved
still remain elusive.
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